PPBT
$3.99
Pre-MarketAs of Mar 17, 8:00 PM UTC
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States.
Historical Price
Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$3.99
Potential Upside
5%
Whystock Fair Value$4.19
Price
UndervaluedFair ValueOvervalued
Fundamentals
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humanized monoclonal antibody that bl...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$4.14M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
-0.74
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-124.46%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
1.24
Recent News
No recent news found.